These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34516583)

  • 1. Seroprevalence of Zika virus in pregnant women from central Thailand.
    Phatihattakorn C; Wongsa A; Pongpan K; Anuwuthinawin S; Mungmanthong S; Wongprasert M; Tassaneetrithep B
    PLoS One; 2021; 16(9):e0257205. PubMed ID: 34516583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence of Flavivirus Neutralizing Antibodies in Thailand by High-Throughput Neutralization Assay: Endemic Circulation of Zika Virus before 2012.
    Yamanaka A; Matsuda M; Okabayashi T; Pitaksajjakul P; Ramasoota P; Saito K; Fukasawa M; Hanada K; Matsuura T; Muramatsu M; Shioda T; Suzuki R
    mSphere; 2021 Aug; 6(4):e0033921. PubMed ID: 34259560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survey on neutralizing antibodies against Zika virus eighteen months post-outbreak in two southern Thailand communities.
    Densathaporn T; Sangthong R; Sakolnapa M; Surasombatpattana S; Kemapunmanus M; Masrinoul P; Yoksan S; McNeil EB; Chongsuvivatwong V
    BMC Infect Dis; 2020 Dec; 20(1):921. PubMed ID: 33272192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of Zika virus neutralizing antibodies in healthy adults in Vietnam during and after the Zika virus epidemic season: a longitudinal population-based survey.
    Nguyen CT; Moi ML; Le TQM; Nguyen TTT; Vu TBH; Nguyen HT; Pham TTH; Le THT; Nguyen LMH; Phu Ly MH; Ng CFS; Takemura T; Morita K; Hasebe F
    BMC Infect Dis; 2020 May; 20(1):332. PubMed ID: 32393198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika Virus.
    Swanstrom JA; Plante JA; Plante KS; Young EF; McGowan E; Gallichotte EN; Widman DG; Heise MT; de Silva AM; Baric RS
    mBio; 2016 Jul; 7(4):. PubMed ID: 27435464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal Analysis of Antibody Cross-neutralization Following Zika Virus and Dengue Virus Infection in Asia and the Americas.
    Montoya M; Collins M; Dejnirattisai W; Katzelnick LC; Puerta-Guardo H; Jadi R; Schildhauer S; Supasa P; Vasanawathana S; Malasit P; Mongkolsapaya J; de Silva AD; Tissera H; Balmaseda A; Screaton G; de Silva AM; Harris E
    J Infect Dis; 2018 Jul; 218(4):536-545. PubMed ID: 29618091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence of Zika and Dengue Virus Antibodies among Migrant Workers, Taiwan, 2017.
    Perng GC; Ho TC; Shih HI; Lee CH; Huang PW; Chung CH; Ko NY; Ko WC; Chien YW
    Emerg Infect Dis; 2019 Apr; 25(4):814-816. PubMed ID: 30882327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of Durable Cross-Neutralizing Antibodies Against Zika Virus from Dengue Virus Infection.
    Collins MH; McGowan E; Jadi R; Young E; Lopez CA; Baric RS; Lazear HM; de Silva AM
    Emerg Infect Dis; 2017 May; 23(5):773-781. PubMed ID: 28418292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune Responses to Dengue and Zika Viruses-Guidance for T Cell Vaccine Development.
    Roth C; Delgado FG; Simon-Lorière E; Sakuntabhai A
    Int J Environ Res Public Health; 2018 Feb; 15(2):. PubMed ID: 29473899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity.
    Lai H; Paul AM; Sun H; He J; Yang M; Bai F; Chen Q
    Vaccine; 2018 Mar; 36(14):1846-1852. PubMed ID: 29490880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-Reaction, Enhancement, and Neutralization Activity of Dengue Virus Antibodies against Zika Virus: A Study in the Mexican Population.
    Montecillo-Aguado MR; Montes-Gómez AE; García-Cordero J; Corzo-Gómez J; Vivanco-Cid H; Mellado-Sánchez G; Muñoz-Medina JE; Gutiérrez-Castañeda B; Santos-Argumedo L; González-Bonilla C; Cedillo-Barrón L
    J Immunol Res; 2019; 2019():7239347. PubMed ID: 31565661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zika convalescent macaques display delayed induction of anamnestic cross-neutralizing antibody responses after dengue infection.
    Valiant WG; Huang YS; Vanlandingham DL; Higgs S; Lewis MG; Mattapallil JJ
    Emerg Microbes Infect; 2018 Jul; 7(1):130. PubMed ID: 30006514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zika Virus Immunoglobulin G Seroprevalence among Young Adults Living with HIV or without HIV in Thailand from 1997 to 2017.
    Choyrum S; Wangsaeng N; Nechba A; Salvadori N; Saisom R; Achalapong J; Putiyanun C; Sabsanong P; Sangsawang S; Patamasingh Na Ayudhaya O; Jourdain G; Ngo-Giang-Huong N; Khamduang W
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35215960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralization Assay for Zika and Dengue Viruses by Use of Real-Time-PCR-Based Endpoint Assessment.
    Wilson HL; Tran T; Druce J; Dupont-Rouzeyrol M; Catton M
    J Clin Microbiol; 2017 Oct; 55(10):3104-3112. PubMed ID: 28794181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient transplacental IgG transfer in women infected with Zika virus during pregnancy.
    Singh T; Lopez CA; Giuberti C; Dennis ML; Itell HL; Heimsath HJ; Webster HS; Roark HK; Merçon de Vargas PR; Hall A; Corey RG; Swamy GK; Dietze R; Lazear HM; Permar SR
    PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007648. PubMed ID: 31449521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-Reactive T Cell Immunity to Dengue and Zika Viruses: New Insights Into Vaccine Development.
    Elong Ngono A; Shresta S
    Front Immunol; 2019; 10():1316. PubMed ID: 31244855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Envelope-Modified Tetravalent Dengue Virus-Like-Particle Vaccine Has Implications for Flavivirus Vaccine Design.
    Urakami A; Ngwe Tun MM; Moi ML; Sakurai A; Ishikawa M; Kuno S; Ueno R; Morita K; Akahata W
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28956764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dengue and Zika Virus Domain III-Flagellin Fusion and Glycan-Masking E Antigen for Prime-Boost Immunization.
    Lin HH; Yang SP; Tsai MJ; Lin GC; Wu HC; Wu SC
    Theranostics; 2019; 9(16):4811-4826. PubMed ID: 31367259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporation of IgG Depletion in a Neutralization Assay Facilitates Differential Diagnosis of Zika and Dengue in Secondary Flavivirus Infection Cases.
    Calvert AE; Boroughs KL; Laven J; Stovall JL; Luy BE; Kosoy OI; Huang CY
    J Clin Microbiol; 2018 Jun; 56(6):. PubMed ID: 29618505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dengue and Zika virus infections are enhanced by live attenuated dengue vaccine but not by recombinant DSV4 vaccine candidate in mouse models.
    Shukla R; Beesetti H; Brown JA; Ahuja R; Ramasamy V; Shanmugam RK; Poddar A; Batra G; Krammer F; Lim JK; Kale S; Lal AA; Swaminathan S; Khanna N
    EBioMedicine; 2020 Oct; 60():102991. PubMed ID: 32949997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.